{"name":"Changchun GeneScience Pharmaceutical Co., Ltd.","slug":"changchun-genescience-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"changchungenescience.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":11,"colorKey":"immunology","drugs":[{"name":"Diprospan","genericName":"Diprospan","slug":"diprospan","indication":"Other","status":"marketed"},{"name":"GenSci004","genericName":"GenSci004","slug":"gensci004","indication":"Growth hormone deficiency","status":"phase_3"},{"name":"GenSci094","genericName":"GenSci094","slug":"gensci094","indication":"Growth hormone deficiency","status":"phase_3"},{"name":"rhGH injection","genericName":"rhGH injection","slug":"rhgh-injection","indication":"Growth hormone deficiency in children","status":"marketed"},{"name":"Cabergoline tablets","genericName":"Cabergoline tablets","slug":"cabergoline-tablets","indication":"Hyperprolactinemia","status":"phase_3"},{"name":"GenSci048","genericName":"GenSci048","slug":"gensci048","indication":"Other","status":"phase_2"},{"name":"PEG-somatropin","genericName":"PEG-somatropin","slug":"peg-somatropin","indication":"Growth hormone deficiency in children","status":"marketed"},{"name":"Placebo RecFSH / follitropin alfa","genericName":"Placebo RecFSH / follitropin alfa","slug":"placebo-recfsh-follitropin-alfa","indication":"Infertility in women undergoing assisted reproductive technology (ART)","status":"phase_3"},{"name":"Progesterone Soft Capsules","genericName":"Progesterone Soft Capsules","slug":"progesterone-soft-capsules","indication":"Treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance","status":"phase_3"},{"name":"genakumab","genericName":"genakumab","slug":"genakumab","indication":"Other","status":"phase_3"},{"name":"somatropin AQ","genericName":"somatropin AQ","slug":"somatropin-aq","indication":"Other","status":"phase_1"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"neuroscience","drugs":[{"name":"Leuprorelin Acetate Microspheres for Injection","genericName":"Leuprorelin Acetate Microspheres for Injection","slug":"leuprorelin-acetate-microspheres-for-injection","indication":"Advanced prostate cancer","status":"phase_3"},{"name":"T Leuprolide Injectable Emulsion","genericName":"T Leuprolide Injectable Emulsion","slug":"t-leuprolide-injectable-emulsion","indication":"Advanced prostate cancer","status":"phase_3"},{"name":"Gentuximab Injection","genericName":"Gentuximab Injection","slug":"gentuximab-injection","indication":"Metastatic colorectal cancer","status":"phase_3"},{"name":"Triptorelin for Injection","genericName":"Triptorelin for Injection","slug":"triptorelin-for-injection","indication":"Prostate cancer","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"EG017 ointment","genericName":"EG017 ointment","slug":"eg017-ointment","indication":"Treatment of psoriasis","status":"phase_2"},{"name":"placebo for genakumab","genericName":"placebo for genakumab","slug":"placebo-for-genakumab","indication":"Rheumatoid Arthritis","status":"phase_3"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Bromocriptine mesylate tablets","genericName":"Bromocriptine mesylate tablets","slug":"bromocriptine-mesylate-tablets","indication":"Hyperprolactinemia","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"infectious","drugs":[{"name":"GS3-007a dry suspension","genericName":"GS3-007a dry suspension","slug":"gs3-007a-dry-suspension","indication":"Type 2 diabetes","status":"phase_2"}]}],"pipeline":[{"name":"Bromocriptine mesylate tablets","genericName":"Bromocriptine mesylate tablets","slug":"bromocriptine-mesylate-tablets","phase":"phase_3","mechanism":"Bromocriptine mesylate is a dopamine D2 receptor agonist that inhibits prolactin secretion and modulates hypothalamic-pituitary function.","indications":["Hyperprolactinemia","Prolactin-secreting pituitary adenoma (prolactinoma)","Acromegaly (adjunctive therapy)","Parkinson's disease (adjunctive therapy)"],"catalyst":""},{"name":"Diprospan","genericName":"Diprospan","slug":"diprospan","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"EG017 ointment","genericName":"EG017 ointment","slug":"eg017-ointment","phase":"phase_2","mechanism":"EG017 ointment is a topical treatment that targets the underlying cause of skin conditions.","indications":["Treatment of psoriasis"],"catalyst":""},{"name":"GenSci004","genericName":"GenSci004","slug":"gensci004","phase":"phase_3","mechanism":"GenSci004 is a recombinant human growth hormone analog designed to promote growth and metabolic effects.","indications":["Growth hormone deficiency","Growth disorders in children"],"catalyst":""},{"name":"GenSci094","genericName":"GenSci094","slug":"gensci094","phase":"phase_3","mechanism":"GenSci094 is a recombinant human growth hormone analog designed to promote growth and metabolic effects.","indications":["Growth hormone deficiency","Growth disorders in pediatric patients"],"catalyst":""},{"name":"Leuprorelin Acetate Microspheres for Injection","genericName":"Leuprorelin Acetate Microspheres for Injection","slug":"leuprorelin-acetate-microspheres-for-injection","phase":"phase_3","mechanism":"Leuprorelin acetate is a GnRH agonist that suppresses luteinizing hormone and follicle-stimulating hormone, leading to decreased sex hormone production.","indications":["Advanced prostate cancer","Endometriosis","Uterine fibroids","Precocious puberty"],"catalyst":""},{"name":"T Leuprolide Injectable Emulsion","genericName":"T Leuprolide Injectable Emulsion","slug":"t-leuprolide-injectable-emulsion","phase":"phase_3","mechanism":"Leuprolide is a GnRH agonist that suppresses luteinizing hormone and follicle-stimulating hormone, leading to reduced sex hormone production.","indications":["Advanced prostate cancer","Endometriosis","Uterine fibroids","Precocious puberty"],"catalyst":""},{"name":"rhGH injection","genericName":"rhGH injection","slug":"rhgh-injection","phase":"marketed","mechanism":"Recombinant human growth hormone (rhGH) binds to growth hormone receptors to stimulate growth, metabolism, and protein synthesis.","indications":["Growth hormone deficiency in children","Growth hormone deficiency in adults","Short stature due to growth hormone insufficiency"],"catalyst":""},{"name":"Cabergoline tablets","genericName":"Cabergoline tablets","slug":"cabergoline-tablets","phase":"phase_3","mechanism":"Cabergoline is a dopamine D2 receptor agonist that inhibits prolactin secretion from the anterior pituitary gland.","indications":["Hyperprolactinemia","Prolactin-secreting pituitary adenoma (prolactinoma)"],"catalyst":""},{"name":"GS3-007a dry suspension","genericName":"GS3-007a dry suspension","slug":"gs3-007a-dry-suspension","phase":"phase_2","mechanism":"GS3-007a dry suspension is a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""},{"name":"GenSci048","genericName":"GenSci048","slug":"gensci048","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Gentuximab Injection","genericName":"Gentuximab Injection","slug":"gentuximab-injection","phase":"phase_3","mechanism":"Gentuximab is a monoclonal antibody that targets and inhibits vascular endothelial growth factor (VEGF) to suppress tumor angiogenesis and blood vessel formation.","indications":["Metastatic colorectal cancer","Non-small cell lung cancer"],"catalyst":""},{"name":"PEG-somatropin","genericName":"PEG-somatropin","slug":"peg-somatropin","phase":"marketed","mechanism":"PEG-somatropin is a pegylated recombinant human growth hormone that binds to growth hormone receptors to promote growth, metabolism, and body composition changes.","indications":["Growth hormone deficiency in children","Growth hormone deficiency in adults"],"catalyst":""},{"name":"Placebo RecFSH / follitropin alfa","genericName":"Placebo RecFSH / follitropin alfa","slug":"placebo-recfsh-follitropin-alfa","phase":"phase_3","mechanism":"Follitropin alfa is a recombinant human follicle-stimulating hormone (FSH) that stimulates ovarian follicle development and estrogen production in women.","indications":["Infertility in women undergoing assisted reproductive technology (ART)","Anovulation and ovulatory dysfunction in women"],"catalyst":""},{"name":"Progesterone Soft Capsules","genericName":"Progesterone Soft Capsules","slug":"progesterone-soft-capsules","phase":"phase_3","mechanism":"Progesterone is a naturally occurring steroid hormone that plays a crucial role in the menstrual cycle and in maintaining the early stages of pregnancy.","indications":["Treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance","Maintenance of early pregnancy"],"catalyst":""},{"name":"Triptorelin for Injection","genericName":"Triptorelin for Injection","slug":"triptorelin-for-injection","phase":"phase_3","mechanism":"Triptorelin for Injection is a synthetic decapeptide analogue of gonadotropin-releasing hormone (GnRH) that acts as a potent agonist.","indications":["Prostate cancer","Premature puberty"],"catalyst":""},{"name":"genakumab","genericName":"genakumab","slug":"genakumab","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"placebo for genakumab","genericName":"placebo for genakumab","slug":"placebo-for-genakumab","phase":"phase_3","mechanism":"This drug is a placebo, meaning it has no active pharmacological effect.","indications":["Rheumatoid Arthritis"],"catalyst":""},{"name":"somatropin AQ","genericName":"somatropin AQ","slug":"somatropin-aq","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNRzdXaW5zb2ZLX0JUVDBydXdlZldSLXNabmJVRUM1aXkzUG5PWnVTQVpzN0hwNTZ2dkpmY0dYazhGakdjYU5PamotNV9mTDlleFA4MVl3RVZPcGRkQ2JFcnpaQjEwUVVQX1Bkc19qdjlaZ3FtV3lMUW5vTTNva2dsUUJUcFJ5TVZKQ3Y2bG1oaWgyWkJHMEgybGtKVHBYVTk4U1JzMXJmWnl4dW9qcHgzcFZaQ3pYWGhJT25ERGl3?oc=5","date":"2026-04-01","type":"pipeline","source":"BioWorld News","summary":"Changchun Genescience Pharmaceuticals discloses new 17β-HSD1 inhibitors - BioWorld News","headline":"Changchun Genescience Pharmaceuticals discloses new 17β-HSD1 inhibitors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxPVzA4RksxZlZJNU9QMVRGYXJRekpLUk5Jb3h6Mzk3UDFPem9zSUtzd2RSQllHbDF3LUdjbEJfYWd3UGV2UmhyT2trQWNfUlR5ZDVLVnlXYXB5czFwVG1mRDEyQWhzNEdac2hCWEk4RDl3aGxSMnpVdTA5U1BrSFBmaGZ1cnZ0MVpNVDktZF9xV0J3ZGRIQk1hbUNKZDJMVlNiUTN5Z0NsWGI5U0ZINnJxNnhWaVpocC1kTHdDWnk1Zl9IemhFQWZsbTZkM0FiaC1YZW1YekxOOHBpRWFWbG55MUQ0bXZCd1p3LS01NDg5cXFoY2Q0M3NrUk9yVjQ2YUlDaUhpeFN2b0loaWhiWW44MmdJTEdNTWtFSFNTemNYTkNEekZkWWc?oc=5","date":"2026-01-22","type":"trial","source":"GlobeNewswire","summary":"Endometriosis Clinical Trial Pipeline Accelerates as 18+ - GlobeNewswire","headline":"Endometriosis Clinical Trial Pipeline Accelerates as 18+","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2025-12-19","type":"deal","source":"Indian Pharma Post","summary":"GenSci, RTW & Yarrow Bioscience strike $1.365 billion global deal for breakthrough graves’ disease therapy - Indian Pharma Post","headline":"GenSci, RTW & Yarrow Bioscience strike $1.365 billion global deal for breakthrough graves’ disease therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxQdm95c3ZvazBVXzlqN0tXMlJQS1NVRWhsRktyUHhIWVluMG0wN0hGY1ZNQ2FfOUhkbXllclVYQlMwVmJEdzdSQ0c4WVVhYzdMSFhwaXlBeFNmT05NUnVXWTU2Vy1OVzRpWGxjUlBtVFltdG16aWRNc1ZoeTk4blV2a1BGWldqc2dvNXkzSW1yZUFHcjA1S1ZwcmhBOW5jM0JiUjh6NmNQRUVlWm1ZTnUzSUdwVEh5cFVUTG5qVmM3dm12UEM5Y0Foc0Jyd2UzZnpHYUN2M3Z6T0Y2ZmkxcGt3WUc0WElEWVppOUtR?oc=5","date":"2025-12-17","type":"deal","source":"BioPharma APAC","summary":"GenSci, RTW And Yarrow Forge US Focused Biotech Partnership To Advance First In Class Thyroid Autoimmune Therapy - BioPharma APAC","headline":"GenSci, RTW And Yarrow Forge US Focused Biotech Partnership To Advance First In Class Thyroid Autoimmune Therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxOLTZoZzNhWm5OR1UxQWpCT044Y0Z4STZrci1WLUpZd0lqZHQ1ZmVvUk1XLUt3ejhVREJ1aVlGYnhsQ0xYWjByLVAxVENia2VlWVJTeUhQMmRod0M5dVpxX3hQQXRMdXhiY2VKemZKczRjTDR4Rl9iNjN5Zk5NbWVJV29ZN0tYVC1TT2dRMmR0S0E4eWRzczVGZVNNcFF4Wndpb243TEpkTGlEdjllaGRSTGNJUC1iYkU3MmdvM2pHbnZ0NTNFd3Zv?oc=5","date":"2025-12-16","type":"deal","source":"BioCentury","summary":"RTW leans into NewCo model with GenSci deal for ocular autoimmune therapy: Deals Report - BioCentury","headline":"RTW leans into NewCo model with GenSci deal for ocular autoimmune therapy: Deals Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AJBVV95cUxNdFUtblN4eXF6Mk5KcUdZdXNIZDA1WlFRWlhlNzMtcC1ON1NCc2huOFMyZjA2SjdJNWRrdERjY1oyclNIUUhvdW5OZld5Y2E3UFJ2Y3FHaGRIWDJWUUh3QmFPVjlNOXFWZC1rZTlMdENVTlRjQ2FROExYUGRINlBCazUtbC10OThtanVqejU2bHhybDdiNFJKeEgtcGRHSG5lTG4tMkhPMWpEYVVGYmlBQjFfdDJNUXVKRkRnMnJXVTBnZWdQLWhzdlVhclZEX3hTSzF2VTJBRHJFUkdHQW5yT1hBUnVJSnpieU1xLUVmMDhxdEQ5ak5yOEhzcFdnN0h5c0ZoSmstNEVTRElOWEY3YzZGdnlLUk9IbWZxQzVFM3oxdkhaVXUxdFEzUV9GYWh4TkxHQ0N5eTk2QjhIdk1PSGtqSkdYbFhwQV9OYjN3NTN3X2NYS3hlRGItU0s?oc=5","date":"2025-12-16","type":"deal","source":"BioSpace","summary":"GenSci and RTW Investments Announce Strategic Partnership on Anti-TSHR Antibody GS-098 (YB-101) for Graves’ Disease and Thyroid Eye Disease, With Global Ex-China Development Being Led by Yarrow Biosci","headline":"GenSci and RTW Investments Announce Strategic Partnership on Anti-TSHR Antibody GS-098 (YB-101) for Graves’ Disease and ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxNTVNXR2VFdWxtSUhGd2syTlVDcHNjYVZZNnNKVEs2dTFKa3lPdEVHVzhjT29OYm1aY3VLTllNSTdzZm8xcnhzcXdxcGhGbTY2TE9EMkdYTjgxSzZvWUlWaldXb1hoMmtoR1FYTlBlR0hrWHY4Q1FyQWZFOF9QaTI2eW85WTZLT0JmTnVyYnVsZnpQVFRkTml0UlZVX09NQ29FcVlPRzJXZGFienFCTWJsNU9fUkU4UlliRkZNQU4yN0FTVm9vWGxuX0JBVzcxXzYwZTRqN01iQkRQMlk2WHJEdGJDTE4tVDJkT3pwQXU5dmJ0RFdPZVhweURib2NIMzVHZUJ1VjNreWtGNUc0Y3JxLThHSUhaUWp0MXZtbFkzSEhVVUlPS0JrOQ?oc=5","date":"2025-10-16","type":"trial","source":"GlobeNewswire","summary":"Thyroid Eye Disease Clinical Trial Pipeline Gains Momentum: - GlobeNewswire","headline":"Thyroid Eye Disease Clinical Trial Pipeline Gains Momentum:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwJBVV95cUxOX0tWV1VaVnlYcXVwVnNxa1o0cDZ6eHQwMDR6VUUzTE9UdlFPVVhKMkFxRTNDUTA4bWo5UnFid0hLaHh2bVpDaGJvbHFTakpsSTF4TUFTSEkwOF9EV215M0d6REs3clN6UHQwZ0Q2bWtxM3Y0VkhSRUxtYVoxbEFweUg3WnYweGNmenkyM21jeGNhcFpQcm1BOWxnNF9LeTNyaFNtZDRFWWFKRUNXbk1hMnFJYkZuWHl5Zk1fSERRcXBoWnpfVFBDR2M1dVNrXy1IMkdzcGFtdzdvWGdWSnY2M0tHWWo5WFVwVG9PZjRwWldZbWt6aFFHUVlVek0yWHBCZUV2UHpmcEI5N0syUXRyT1A2ckpOdmc?oc=5","date":"2025-08-07","type":"trial","source":"GlobeNewswire","summary":"Cancer Cachexia Clinical Trial Pipeline Shows Potential - GlobeNewswire","headline":"Cancer Cachexia Clinical Trial Pipeline Shows Potential","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFA0d2hTQTNvckVVM090MVFZYnNrV00xbTYxZV9SekNNRkRFVnBBTXpLVDM3LUhPY1V1VnkzU1dNWG1OamQ3X3ViYW9YRlNIWWEtdHhPN0c0TjVhQXBXUUdrT2RZeEdBY1BwaDhHbS1rMlZHMGJabDdKbUFGSVZpcDg?oc=5","date":"2023-12-23","type":"pipeline","source":"BioSpace","summary":"GenSci Launches Global Innovation Hub in Shanghai - BioSpace","headline":"GenSci Launches Global Innovation Hub in Shanghai","sentiment":"neutral"}],"patents":[],"drugCount":19,"phaseCounts":{"phase_3":12,"marketed":3,"phase_2":3,"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}